These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38233283)
1. Decoding anaphylatoxins: unveiling the molecular mechanisms of complement receptor activation and signaling. Fernández FJ; Vega MC Trends Biochem Sci; 2024 Apr; 49(4):280-282. PubMed ID: 38233283 [TBL] [Abstract][Full Text] [Related]
2. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors. Yadav MK; Maharana J; Yadav R; Saha S; Sarma P; Soni C; Singh V; Saha S; Ganguly M; Li XX; Mohapatra S; Mishra S; Khant HA; Chami M; Woodruff TM; Banerjee R; Shukla AK; Gati C Cell; 2023 Oct; 186(22):4956-4973.e21. PubMed ID: 37852260 [TBL] [Abstract][Full Text] [Related]
3. Chimeric receptors of the human C3a receptor and C5a receptor (CD88). Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065 [TBL] [Abstract][Full Text] [Related]
4. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins. Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960 [TBL] [Abstract][Full Text] [Related]
5. The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation. Buelli S; Imberti B; Morigi M Nephron; 2024; 148(10):712-723. PubMed ID: 38452744 [TBL] [Abstract][Full Text] [Related]
6. The Complement C3a Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209 [TBL] [Abstract][Full Text] [Related]
7. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma. Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927 [TBL] [Abstract][Full Text] [Related]
8. Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. Ajona D; Ortiz-Espinosa S; Pio R Semin Cell Dev Biol; 2019 Jan; 85():153-163. PubMed ID: 29155219 [TBL] [Abstract][Full Text] [Related]
10. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Peng Q; Li K; Sacks SH; Zhou W Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884 [TBL] [Abstract][Full Text] [Related]
11. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage. Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169 [TBL] [Abstract][Full Text] [Related]
13. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800 [TBL] [Abstract][Full Text] [Related]
14. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells. Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592 [TBL] [Abstract][Full Text] [Related]
16. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells. Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538 [TBL] [Abstract][Full Text] [Related]
17. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538 [TBL] [Abstract][Full Text] [Related]
18. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Li XX; Clark RJ; Woodruff TM Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293 [TBL] [Abstract][Full Text] [Related]
19. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. Kretzschmar T; Jeromin A; Gietz C; Bautsch W; Klos A; Köhl J; Rechkemmer G; Bitter-Suermann D Eur J Immunol; 1993 Feb; 23(2):558-61. PubMed ID: 7679650 [TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of human and murine C5a anaphylatoxins. Schatz-Jakobsen JA; Yatime L; Larsen C; Petersen SV; Klos A; Andersen GR Acta Crystallogr D Biol Crystallogr; 2014 Jun; 70(Pt 6):1704-17. PubMed ID: 24914981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]